Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Bone Marrow Transplantation Using c-myb Antisense Oligodeoxynucleotide in CML
NCT00002592Phase 2Completed
- Sponsor
- Abramson Cancer Center
- Start
- Jun 1993
- Primary completion
- Aug 2002
- Modality
- Modified DNA Oligonucleotides, Single-strand DNA, Antisense Oligonucleotides (ASOs)
- Countries
- 1
01
Overview
A Phase 2 trial of G-4460 in chronic myelogenous leukemia (CML), sponsored by Abramson Cancer Center. Started Jun 1993; status: completed.
02
Drugs
G-4460
03
Conditions
chronic myelogenous leukemia (CML)
Beyond the preview
Go deeper on NCT00002592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002592.